[go: up one dir, main page]

AU4513099A - Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone) - Google Patents

Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)

Info

Publication number
AU4513099A
AU4513099A AU45130/99A AU4513099A AU4513099A AU 4513099 A AU4513099 A AU 4513099A AU 45130/99 A AU45130/99 A AU 45130/99A AU 4513099 A AU4513099 A AU 4513099A AU 4513099 A AU4513099 A AU 4513099A
Authority
AU
Australia
Prior art keywords
alpha
estr
methyltestosterone
cycloalkyl
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45130/99A
Inventor
Dirk Leysen
Jaap Van Der Louw
Hendrikus Adrianus Antonius Van Der Voort
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU4513099A publication Critical patent/AU4513099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU45130/99A 1998-06-19 1999-06-14 Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone) Abandoned AU4513099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98202051 1998-06-19
EP98202051 1998-06-19
PCT/EP1999/004101 WO1999067270A1 (en) 1998-06-19 1999-06-14 Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)

Publications (1)

Publication Number Publication Date
AU4513099A true AU4513099A (en) 2000-01-10

Family

ID=8233830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45130/99A Abandoned AU4513099A (en) 1998-06-19 1999-06-14 Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)

Country Status (4)

Country Link
AR (1) AR018888A1 (en)
AU (1) AU4513099A (en)
CO (1) CO5050334A1 (en)
WO (1) WO1999067270A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
TW200403065A (en) 2002-05-30 2004-03-01 Akzo Nobel Nv New etonogestrel esters
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت method and pharmaceutical compositions for reliable achievements of acceptable serum testosterone levels
TWI530504B (en) * 2014-12-01 2016-04-21 臺灣永光化學工業股份有限公司 Synthetic method of testosterone alkanoate
CA3184810A1 (en) * 2020-06-11 2021-12-16 Ash Stevens, Llc Monomeric and oligomeric compound embodiments as contraceptives and therapies and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948790A (en) * 1987-08-26 1990-08-14 Sydney Archer Long-acting androgenic compounds and pharmaceutical compositions thereof
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation

Also Published As

Publication number Publication date
CO5050334A1 (en) 2001-06-27
WO1999067270A1 (en) 1999-12-29
AR018888A1 (en) 2001-12-12

Similar Documents

Publication Publication Date Title
AU3980395A (en) 2-cyanoacrylic acid esters
IL154148A0 (en) 6.alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
AU1348095A (en) Fatty acid derivatives
AU5734096A (en) Diamide-dicarboxylic acid microspheres
AU5479490A (en) Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
ZA986490B (en) Hair conditioning compositions containing alpha or beta hydroxy acid esters
AU9537098A (en) 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein
AU1097299A (en) High-precision computer-aided microscope system
AU6840596A (en) Novel estrogens
AU5303596A (en) Graphite-containing compositions
EP1002847B8 (en) Self-adhesive composition
AU4513099A (en) Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
AU9510398A (en) Main stage catheterization instrument
IL141850A0 (en) HIGH PURITY COMPOSITION COMPRISING (7α,17alpha;)- 17-HYDROXY- 7-METHYL-19-NOR -17 -PREGN-5(10)-EN-20-YN-3-ONE
AU1064895A (en) 3-methoxy-phenyl-acrylic acid methyl esters
AU6659998A (en) Tazarotene-induced gene 3 (tig3)
AU5345798A (en) Fructan-polycarboxylic acid
AU3507495A (en) Process for the stereoselective reduction of steroid enelactams
AU6597396A (en) Novel 3-amido-triiodophenyl esters as x-ray contrast agents
AU2629295A (en) Trifluoromethylquinolinecarboxylic acid derivative
AU1134095A (en) Creep-resistant iron-chromium-aluminum alloy substantially free of molybdenum
AU7534894A (en) 3-methoxy-2-phenylacrylic acid methyl esters
AU1654692A (en) Acid alpha-amylase
AU2263695A (en) Messaging system
AU4343196A (en) Cyclohex(en)yl-propionitriles

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase